Evidence map

ArticleFrontiers in endocrinology2022

Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study.

Hwi Seung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36387922